Appearance of the frequency doubling stimulus in normal subjects and patients with glaucoma.
نویسندگان
چکیده
PURPOSE To determine whether the spatial structure of the frequency doubling technology (FDT) perimetry stimulus is visible at detection-contrast threshold in normal observers and those with glaucoma and to assess its perceived spatial frequency at threshold and suprathreshold contrast. METHODS Three subject groups were assessed: 10 young normal observers (aged <40 years), 10 older normal observers (aged >50 years), and 10 subjects with glaucoma. Detection thresholds for centrally and eccentrically presented 10 degrees squares, 0.25-cyc/deg, 25-Hz counterphase flicker sine-wave gratings were obtained by using a yes-no staircase procedure. Eccentric locations were in areas of loss of FDT sensitivity (< or =21 degrees ) in subjects with glaucoma, or at 7 degrees or 21 degrees inferonasally in normal observers. Resolution-contrast thresholds were determined by a two-alternative, forced-choice staircase procedure in which subjects selected the orientation of the grating stimulus tilted at +/-45 degrees. Perceived spatial frequency was determined by having subjects alter the spatial frequency of a temporally interleaved stationary sine-wave grating to match the FDT stimulus. RESULTS No significant difference was found between detection- and resolution-contrast thresholds, implying that spatial structure was visible at detection threshold. In general, subjects perceived the spatial structure to have a spatial frequency closer to doubled than to veridical, although the young normal subjects reported a lower apparent spatial frequency than older individuals. CONCLUSIONS When instructed as for clinical testing, subjects respond to the presence of the structure of the grating, and perceive the FDT stimulus to have a spatial frequency greater than its true spatial frequency. These findings were consistent across both normal observers and those with glaucoma, at both central and eccentric test locations.
منابع مشابه
Performance of efficient test procedures for frequency-doubling technology perimetry in normal and glaucomatous eyes.
PURPOSE To validate the clinical performance of two new efficient threshold-estimation procedures for frequency-doubling technology (FDT) perimetry in both visually normal individuals and patients with glaucomatous visual field loss. METHODS Forty-one normal subjects (mean age, 48.3 +/- 11.6 years) and 50 patients with glaucomatous visual field loss (mean age, 72.7 +/- 10.0 years) were tested...
متن کاملDepression and Quality of Life in Patients with Glaucoma
Purpose: To investigate the frequency of depression and quality of life in patients with glaucoma. Methods: This cross-sectional study included 204 patients (102 males and 102 females) with a mean age of 58.9±11.96 and a range of 40 to 85 years old. Achromatic perimetry was performed, using the HFA SITA-standard 24-2. Severity was stratified according to the Nelson Glaucoma Severity Scale (base...
متن کاملTest-retest variability of frequency-doubling perimetry and conventional perimetry in glaucoma patients and normal subjects.
PURPOSE To compare the test-retest variability characteristics of frequency-doubling perimetry, a new perimetric test, with those of conventional perimetry in glaucoma patients and normal control subjects. METHODS The study sample contained 64 patients and 47 normal subjects aged 66.16+/-11.86 and 64.26+/-7.99 years (mean +/- SD), respectively. All subjects underwent frequency-doubling perime...
متن کاملGlutathione s-transferase M1 and T1 genetic polymorphisms in Iranian patients with glaucoma
Objective(s):Glaucoma is the second leading cause of blindness and it is related to oxidative stress based on numerous studies. Glutathione S-transferases (GSTs) are members of multigenic family, which have important role in cells as an antioxidant. In the present study, we examined the polymorphism of GSTT1 and GSTM1 deletion genotypes (T0M1, T1M0, and T0M0) in 100 Glaucoma patients (41with pr...
متن کاملEffect of brimonidine on retinal vascular autoregulation and short-term visual function in normal tension glaucoma.
PURPOSE To assess whether brimonidine 0.15% alters retinal vascular autoregulation and short-term visual function in normal tension glaucoma patients who demonstrate retinal vascular dysregulation. DESIGN Nonrandomized clinical trial. METHODS In this prospective study, 46 normal tension glaucoma patients not previously treated with brimonidine underwent retinal vascular autoregulation testi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Investigative ophthalmology & visual science
دوره 44 3 شماره
صفحات -
تاریخ انتشار 2003